Compounds > cordycepin
Page last updated: 2024-08-17

cordycepin and B16 Melanoma

cordycepin has been researched along with B16 Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagota, S; Kunitomo, M; Nakamura, K; Shinozuka, K; Yoshikawa, N1
Kagota, S; Kunitomo, M; Nakamura, K; Shinozuka, K; Yamaguchi, Y; Yoshikawa, N1
Kagota, S; Kunitomo, M; Nakamura, K; Shinozuka, K; Takeuchi, C; Yamada, S; Yoshikawa, N1
Adams, EG; Bhuyan, BK; Folz, BA; Smith, KS1

Other Studies

4 other study(ies) available for cordycepin and B16 Melanoma

ArticleYear
Inhibitory effect of cordycepin on hematogenic metastasis of B16-F1 mouse melanoma cells accelerated by adenosine-5'-diphosphate.
    Anticancer research, 2009, Volume: 29, Issue:10

    Topics: Adenosine Diphosphate; Animals; Antineoplastic Agents; Deoxyadenosines; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Platelet Aggregation; Specific Pathogen-Free Organisms

2009
Antitumour activity of cordycepin in mice.
    Clinical and experimental pharmacology & physiology, 2004, Volume: 31 Suppl 2

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxyadenosines; Drug Screening Assays, Antitumor; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Skin Neoplasms; Tumor Burden

2004
Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression.
    Naunyn-Schmiedeberg's archives of pharmacology, 2008, Volume: 377, Issue:4-6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cordyceps; Cyclin D1; Deoxyadenosines; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Melanoma, Experimental; Mice; Protein Binding; Radioligand Assay; Receptor, Adenosine A3; Signal Transduction; Wnt Proteins

2008
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Azacitidine; Benzofurans; Caffeine; Cell Survival; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Cyclohexanecarboxylic Acids; Cyclohexenes; Decitabine; Deoxyadenosines; DNA; Dose-Response Relationship, Drug; Drug Synergism; Duocarmycins; Indoles; Melanoma, Experimental; Melphalan; Mutagens; Organoplatinum Compounds; Pentoxifylline; Tumor Cells, Cultured

1995